The 2022 ITAC evidence-based clinical practice guidelines: New update from the International Initiative on Thrombosis and Cancer to improve the care in patients with cancer-associated thrombosis - 31/08/22

C. Frere ^{a, ⁎} , D. Farge ^{b, c, d}, J. Douketis ^e, J.M. Connors ^f

^a Inserm UMRS 1166, GRC 27 GRECO, DMU BioGeM, AP–HP, Sorbonne université, Paris, France 

^b Internal Medicine Unit (UF 04): CRMR MATHEC, Maladies Auto-immunes et Thérapie Cellulaire, Saint-Louis Hospital, AP–HP, Nord-université de Paris, Paris, France 

^c Université de Paris, Institut Universitaire d’Hématologie, EA 3518, Paris, France 

^d Department of Medicine, Research Institute of the McGill University Health Centre, McGill University, Montreal PQ, Canada 

^e Department of Medicine, McMaster University, Hamilton, Canada 

^f Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA 

^⁎Corresponding author. Department of hematology, Pitié-Salpêtrière hospital, Sorbonne université, AP–HP, 47-83, boulevard de l’Hôpital, 75013 Paris, France.Department of hematology, Pitié-Salpêtrière hospital, Sorbonne université, AP–HP47-83, boulevard de l’HôpitalParis75013France